| Literature DB >> 25546624 |
Carlos Henrique Miguita1, Carolina da Silva Barbosa2, Lidilhone Hamerski3, Ulana Chaves Sarmento4, José Nicácio do Nascimento5, Walmir Silva Garcez6, Fernanda Rodrigues Garcez7.
Abstract
Chemical investigation of Guarea kunthiana fruits, guided by their effect on the reproductive cycle of engorged females of the cattle tick Rhipicephalus (Boophilus) microplus-a major economic problem to the livestock industry worldwide-led to isolation of 3β-O-tigloylmelianol, a new protolimonoid, from the bioactive hexane phase obtained by partitioning the crude ethanol extract. An adult immersion test was performed. The compound strongly inhibited egg-laying and hatchability (99.2% effectiveness at a 0.01% concentration). Melianone, isolated from the same phase, yielded unremarkable results in the adult immersion test. From the dichloromethane phase, melianol, melianodiol, meliantriol, and a new protolimonoid, 3β-O-tigloylmeliantriol, were isolated, all of which, in the same manner as melianone, exhibited unremarkable results in the test. The structures of new and known compounds were mostly established by 1D- and 2D-NMR analyses and mass spectrometry data. This is the first report on the bioactivity of protolimonoids on the reproductive cycle of engorged females of R. (B.) microplus. 3β-O-Tigloylmelianol proved a promising candidate for the development of a biocontrol agent against the cattle tick investigated, as an alternative to environmentally hazardous synthetic acaricides.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25546624 PMCID: PMC6272232 DOI: 10.3390/molecules20010111
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Means ± SD of % of egg conversion (PEC), hatching % (HP), and product effectiveness (PE) for engorged females of R. microplus treated with the ethanol (EtOH) extract of G. kunthiana fruits and phases obtained from its partition—namely, aqueous (H2O), hexane, dichloromethane (CH2Cl2) and hydromethanolic (MeOH-H2O) phases at different concentrations.
| Extract/Phases | Concentration (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0.20 | 0.10 | 0.05 | |||||||
| PEC | HP | PE | PEC | HP | PE | PEC | HP | PE | |
| EtOH | 2.6 ± 1.5 * | 8.9 ± 1.2 * | 99.5 ± 0.3 * | 18.7 ± 6.4 * | 23.3 ± 8.8 * | 90.2 ± 6.8 * | 33.2 ± 3.4 * | 16.2 ± 7.7 * | 89.0 ± 4.1 * |
| H2O | 55.7 ± 3.7 | 93.4 ± 2.8 | 1.5 ± 3.5 | 53.7 ± 6.7 | 97.8 ± 2.3 | 4.0 ± 1.1 | 54.8 ± 1.2 | 95.6 ± 0.1 | 0.6 ± 1.8 |
| Hexane | 0.0 ± 0.0 * | 0.0 ± 0.0 * | 100.0 ± 0.0* | 4.1 ± 7.1 * | 4.8 ± 8.2 * | 98.8 ± 2.0 * | 5.6 ± 5.2 * | 9.7 ± 8.7 * | 98.3 ± 1.7 * |
| CH2Cl2 | 47.1 ± 4.6 | 91.4 ± 3.8 | 9.6 ± 3.3 | 48.6 ± 2.2 | 94.1 ± 6.3 | 2.5 ± 1.1 | 48.3 ± 2.2 | 98.3 ± 2.8 | 4.1 ± 1.9 |
| MeOH-H2O | 52.0 ± 2.2 | 92.7 ± 1.3 | 16.5 ± 4.1 | 48.9 ± 3.5 | 97.2 ± 2.5 | 17.6 ± 7.9 | 53.3 ± 1.0 | 96.9 ± 2.7 | 10.7 ± 1.0 |
ANOVA; Tukey post-hoc comparison; * p < 0.05; Control: PEC = 55.4% ± 3.9%; HP = 98.3% ± 4.6%.
Figure 1Effects (mean ± SD) of ethanol extract and phases obtained from its partition (each at 0.2%) vs. effect of control on % of egg conversion (PEC) and hatching % (HP) for engorged females of R. (B.) microplus. ANOVA; Tukey post-hoc comparison.
Means ± SD of % of egg conversion (PEC), hatching % (HP), and product effectiveness (PE) for engorged females of R. microplus treated with different concentrations of fractions A–H obtained from the bioactive hexane phase.
| Fractions | Concentration (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0.1 | 0.05 | 0.025 | |||||||
| PEC | HP | PE | PEC | HP | PE | PEC | HP | PE | |
| A | 45.6 ± 3.4 | 90.3 ± 7.1 | 9.1 ± 4.0 | 44.4 ± 2.0 | 96.5 ± 3.0 | 5.8 ± 2.0 | 43.1 ± 2.6 | 99.2 ± 1.4 | 5.9 ± 1.9 |
| B | 40.8 ± 2.9 | 91.5 ± 3.5 | 25.8 ± 8.2 | 47.4 ± 3.1 | 92.5 ± 11.0 | 13.7 ± 2.1 | 44.8 ± 2.0 | 99.2 ± 1.4 | 1.5 ± 0.1 |
| C | 44.2 ± 1.4 | 93.8 ± 4.4 | 15.2 ± 6.4 | 45.0 ± 3.3 | 97.5 ± 2.5 | 10.2 ± 3.6 | 44.4 ± 2.4 | 99.2 ± 1.4 | 10.5 ± 6.0 |
| D | 0.3 ± 0.2 * | 17.0 ± 2.9 * | 98.9 ± 0.1 * | 4.8 ± 2.4 * | 19.8 ± 5.4 * | 97.7 ± 1.3 * | 10.3 ± 5.4 * | 20.8 ± 7.2 * | 95.9 ± 3.1 * |
| E | 0.1 ± 0.1 * | 21.6 ± 1.0 * | 99.9 ± 0.0 * | 2.6 ± 0.6 * | 20.6 ± 4.2 * | 98.9 ± 0.2 * | 4.5 ± 1.2 * | 10.9 ± 1.7 * | 99.0 ± 0.1 * |
| F | 45.9 ± 2.2 | 88.0 ± 7.5 | 11.7 ± 5.9 | 46.3 ± 4.2 | 96.6 ± 3.0 | 2.0 ± 2.1 | 46.7 ± 3.4 | 96.3 ± 3.4 | 1.4 ± 1.1 |
| G | 41.0 ± 2.5 | 93.3 ± 11.6 | 19.0 ± 3.6 | 47.5 ± 1.6 | 88.8 ± 6.2 | 11.0 ± 4.8 | 43.3 ± 1.1 | 98.3 ± 1.4 | 10.3 ± 0.9 |
| H | 46.3 ± 5.8 | 95.3 ± 4.3 | 11.6 ± 3.0 | 50.7 ± 6.7 | 86.1 ± 11.3 | 12.8 ± 1.5 | 48.1 ± 2.2 | 98.6 ± 2.5 | 5.0 ± 1.5 |
ANOVA; Tukey post-hoc comparison; * p < 0.05; Control: PEC = 54.4% ± 2.8%; HP = 97.1% ± 4.6%.
Figure 2Structures of protolimonoids 1–6 isolated from G. kunthiana.
1H- (300.13 MHz) and 13C- (75.47 MHz) NMR data (CDCl3, TMS δ = 0) for 3β-O-tigloylmelianol (1) and 3β-O-tigloylmeliantriol (4).
| Position | 1 | 4 | ||
|---|---|---|---|---|
| δC | δH, mult. ( | δC | δH, mult. ( | |
| 1 | 36.7 | 1.18–1.24, m | 36.8 | 1.17–1.26, m |
| 1.62–1.70, m | 1.59–1.69, m | |||
| 2 | 23.8 | 1.87–2.01, m | 23.8 | 1.91–2.01, m |
| 2.03–2.16, m | 2.05–2.17, m | |||
| 3 | 81.0 | 4.52, dd (10.9, 3.8) | 81.0 | 4.52, dd (10.8, 4.1) |
| 4 | 38.1 | 38.1 | ||
| 5 | 50.8 | 1.41, dd (11.7, 5.5) | 50.8/50.9 | 1.40, dd (11.5, 5.7) |
| 6 | 24.1 | 1.52, dd (11.7, 5.4) | 24.1 | 1.61–1.71, m |
| 1.67, td (11.7, 2.6) | ||||
| 7 | 117.9/118.0 | 5.23, brd (2.6) | 117.8/117.9 | 5.25, brd (4.6) |
| 8 | 145.5 | 145.5/145.6 | ||
| 9 | 48.7/49.6 | 2.22, t (7.6)/2.23, t (2.6) | 48.7/48.9 | 2.22, t (7.6)/2.23, t (7.6) |
| 10 | 34.9 | 34.9 | ||
| 11 | 17.5 | 1.48, dt (7.6, 2.5) | 17.5 | 1.44–1.54, m |
| 12 | 35.2 | 1.36, dt (10.6, 2.5) | 31.5 | 1.45–1.55, m |
| 2.04–2.16, m | 1.65, dt (12.2, 3.4) | |||
| 13 | 43.6/43.8 | 43.5/43.6 | ||
| 14 | 50.4 | 50.7/51.0 | ||
| 15 | 34.2 | 1.42–1.60, m | 34.2 | 1.41–1.57, m |
| 16 | 27.4 | 1.23–1.37, m | 27.2 | 1.80–1.90, m |
| 1.78–1.94, m | ||||
| 17 | 45.2/47.1 | 1.98-2.10, m/1.91-2.06, m | 45.2 | 1.96–2.03, m |
| 18 | 22.5/23.2 | 0.83, s | 23.2/22.4 | 0.81, s |
| 19 | 13.1 | 0.75, s | 13.1 | 0.75, s |
| 20 | 31.7/33.8 | 1.43–1.57, m | 46.4 | 1.88–1.98, m |
| 1.60–1.79, m | ||||
| 21 | 97.8/ 101.8 | 5.30, d (2.5)/5.34, d (2.6) | 96.8/102.2 | 5.23, brs/5.31, brs |
| 22 | 31.3/31.5 | 1.38–1.48, m | 30.3 | 1.84–1.91, m |
| 1.94–2.02, m | ||||
| 23 | 77.0/78.4 | 3.84, dt (9.5, 75)/ | 77.0/78.6 | 4.32–4.35, m/ |
| 3.90, ddd (10.6, 7.7, 5.1) | 4.49–4.54, m | |||
| 24 | 65.4/67.8 | 2.68, d (7.5)/2.83, d (7.5) | 75.0/75.8 | 3.11, brs/3.19, brs |
| 25 | 57.2/57.9 | 73.1/73.6 | ||
| 26 | 19.2/19.4 | 1.28, s | 26.7 | 1.22, s |
| 27 | 24.9/25.0 | 1.28, s | 26.7 | 1.25, s |
| 28 | 27.6 | 0.83, s | 27.6 | 0.83, s |
| 29 | 16.0 | 0.95, s | 16.0 | 0.95, s |
| 30 | 27.3 | 0.95, s | 27.3 | 0.96, s |
| 1' | 167.9 | 168.0 | ||
| 2' | 129.2 | 129.1 | ||
| 3' | 136.7 | 6.81, brq (7.1) | 136.7 | 6.82, qq (6.8,1.3) |
| 4' | 14.3 | 1.76, d (7.1) | 14.3 | 1.76, d (6.8) |
| 5' | 12.1 | 1.80, brs | 12.0 | 1.81, d (1.3) |
Figure 3Key HMBC correlations for 1 and 4.
Means ± SD of % of egg conversion (PEC), hatching % (HP), and product effectiveness (PE) for engorged females of R. microplus treated with different concentrations of 3β-O-tigloylmelianol (1) and melianone (3).
| Compound | Concentration (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.005 | 0.0025 | |||||||
| PEC | HP | PE | PEC | HP | PE | PEC | HP | PE | |
| 4.4 ± 4.0 * | 6.1 ± 5.4 * | 99.2 ± 0.7 * | 24.4 ± 5.3 * | 8.1 ± 3.9 * | 96.1 ± 0.9 * | 27.2 ± 10.1 * | 18.7 ± 7.1 * | 88.4 ± 8.1 * | |
| 42.7 ± 1.7 | 85.7 ± 16.5 | 29.7 ± 15.8 | 44.0 ± 1.6 | 92.6 ± 4.4 | 22.2 ± 2.0 | 48.8 ± 4.4 | 92.1 ± 3.1 | 14.0 ± 1.2 | |
ANOVA; Tukey post-hoc comparison; * p < 0.05; Control: PEC = 53.1% ± 5.4%; HP = 98.5% ± 0.8%.
Figure 4Effects (mean ± SD) of compounds 1 and 3 (each at 0.01%) and compounds 2, 4–6 (each at 0.015%) vs. effect of controls on % of egg conversion (PEC) and hatching % (HP) for engorged females of R. (B.) microplus. ANOVA; Tukey post-hoc comparison.
Means ± SD of % of egg conversion (PEC), hatching % (HP), and product effectiveness (PE) for engorged females of R. microplus treated with different concentrations of melianol (2), 3β-O-tigloylmeliantriol (4), meliantriol (5) and melianodiol (6).
| Compound | Concentration (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0.015 | 0.0075 | 0.00375 | |||||||
| PEC | HP | PE | PEC | HP | PE | PEC | HP | PE | |
| 53.5 ± 3.7 | 95.5 ± 5.8 | 3.6 ± 1.4 | 51.4 ± 1.2 | 97.3 ± 1.8 | 5.5 ± 0.5 | 50.0 ± 1.5 | 100.0 ± 0.0 | 3.4 ± 2.9 | |
| 52.5 ± 3.5 | 96.4 ± 3.2 | 12.5 ± 5.2 | 53.0 ± 1.7 | 97.7 ± 2.3 | 10.5 ± 1.1 | 55.0 ± 1.1 | 98.5 ± 2.6 | 6.3 ± 4.2 | |
| 53.5 ± 4.4 | 95.7 ± 1.3 | 3.0 ± 0.1 | 52.4 ± 1.5 | 98.3 ± 2.9 | 2.4 ± 0.3 | 53.5 ± 1.0 | 98.4 ± 1.6 | 1.17 ± 0.4 | |
| 53.8 ± 1.6 | 96.7 ± 1.7 | 1.8 ± 0.9 | 52.5 ± 1.3 | 99.5 ± 0.8 | 0.9 ± 0.1 | 53.2 ± 0.8 | 98.3 ± 2.9 | 0.97 ± 0.9 | |
ANOVA; Tukey post-hoc comparison; Control: PEC = 55% ± 0.8%; HP = 98.3% ± 2.9%.